Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Checks and balances: Interplay of RTKs and PTPs in cancer progression
Sarita K. Sastry
,
Lisa A. Elferink
Educational Affairs
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
35
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Checks and balances: Interplay of RTKs and PTPs in cancer progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Progression
100%
Receptor Tyrosine Kinase
100%
In Cancer
100%
Checks-and-balances
100%
Protein Tyrosine Phosphatase 1B (PTP1B)
100%
Targeted Therapy
42%
Acquired Resistance
42%
Tumor
28%
Cancer Patients
14%
Inhibitory Effect
14%
Tumor Suppressor
14%
Tumor Progression
14%
Possible Mechanisms
14%
Clinical Setting
14%
Molecular Therapeutics
14%
Gain-of-function
14%
Oncogene
14%
Loss Function
14%
Oncogenic Signaling
14%
Overcoming Resistance
14%
Clinical Relapse
14%
Medicine and Dentistry
Cancer Growth
100%
Protein Tyrosine Kinase
100%
Protein Tyrosine Phosphatase
100%
Targeted Therapy
42%
Kinase Signaling
28%
Tumor
28%
Malignant Neoplasm
14%
Carcinogenesis
14%
Tumor Progression
14%
Cell Signaling Pathway
14%
Oncogene
14%
Tumor Suppressor Protein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Protein Tyrosine Kinase
100%
Protein Tyrosine Phosphatase
100%
Malignant Neoplasm
14%
Carcinogenesis
14%
Tumor Growth
14%
Tumor Suppressor Protein
14%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Protein Tyrosine Phosphatase
100%
Targeted Therapy
42%
Tumor Suppressor Protein
14%
Carcinogenesis
14%
Tumor Progression
14%
Oncogene
14%
Neuroscience
Receptor Tyrosine Kinase
100%
Protein Tyrosine Phosphatase
100%
Oncogene
14%
Carcinogenesis
14%
Tumor Suppressor Protein
14%